Home
About
Overview
Sharing Data
ORCID
Help
History (73)
Thymus Plant
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.
The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage.
Isenberger, Johnny
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
See All 73 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
Landreth G, Jiang Q, Mandrekar S, Heneka M. PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics. 2008 Jul; 5(3):481-9.
View in:
PubMed
subject areas
Alzheimer Disease
Animals
Antipsychotic Agents
Humans
PPAR gamma
authors with profiles
Michael Thomas Heneka MD